The global contract research organization Worldwide Clinical Trials is making an acquisition of Catalyst Clinical Research.

Expansion will increase production volume and scale manufacturing capacity for next-gen drugs for metabolic conditions.

Borealis AG will invest €49 million to expand production of advanced polypropylene grades at its manufacturing site in ...

GSK has agreed to acquire RAPT Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing novel ...

Alteogen and Tesaro, a subsidiary of GSK, have entered an exclusive license agreement concerning a subcutaneous formulation of dostarlimab.

Qosina has released its New Product Preview, showcasing more than 500 newly added components designed to help engineers solve ...

Harbour BioMed announced its wholly owned subsidiary is exercising a warrant agreement to acquire common stock in Spruce ...

AstraZeneca will buy AbelZeta Pharma’s 50% share of development and commercialization rights in China for a CAR-T therapy for ...

suitable for safely storing and administering highly sensitive biologics, including cell and gene therapies, biosimilars, and ...

Syngene International, a global CRDMO, has extended its long-standing strategic collaboration with Bristol Myers Squibb ...

Emmecell, a clinical-stage biotechnology company, has appointed Ramin Valian as Chief Executive Officer (CEO).

The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...